The Amputation Surgical Site Infection Trial (ASSIT)

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

October 8, 2013

Primary Completion Date

March 1, 2014

Study Completion Date

January 2, 2017

Conditions
Wound InfectionAmputation Wound
Interventions
DRUG

Co-amoxiclav

Augmentin 1.2g IV three times daily for 24 hours. If the patient is randomised to the 5-day duration antibiotic arm then Augmentin 625mg oral tablets three times daily are added to the 24 hour course for a further 4 days.

DRUG

Iodine

Intra-operative skin preparation prior to incision to skin.

DRUG

Metronidazole

500mg IV three times daily for 24 hours. If the patient is randomised to 5-day duration arm, then another 4 days of oral metronidazole at 400mg three times daily is added to the course

DRUG

Chlorhexidine

Alcoholic Chlorhexidine skin pre-op preparation

DRUG

Teicoplanin

Teicoplanin 400mg on induction. If penicillin allergic and on 5-day antibiotic arm then add clindamycin 300mg 4 times daily for further 4 days

DRUG

Clindamycin

Clindamycin 300mg 4 times daily orally to be used in case of penicillin allergy

Trial Locations (1)

HU3 2JZ

Hull Royal Infirmary, Hull

All Listed Sponsors
collaborator

University of Hull

OTHER

lead

Hull University Teaching Hospitals NHS Trust

OTHER_GOV

NCT02018094 - The Amputation Surgical Site Infection Trial (ASSIT) | Biotech Hunter | Biotech Hunter